Ondansetrn ODT 8MG 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FAXAN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,627
Award facts
- Contract value 100% obligated
- $13,627.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $13,627.15 delivery order to AmerisourceBergen Drug Corp on March 18, 2026, for ondansetron 8 mg tablets (30-count). The order was placed under the DLA Troop Support Medical IDC SPE2DX, a $999,999,999 global pharmaceutical supply vehicle through December 2026.
Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of March 19, 2026. No set-aside applied to this competitive award.
Quick answers
Who was awarded contract SPE2DR26FAXAN?
SPE2DR26FAXAN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 18, 2026.
How much is contract SPE2DR26FAXAN worth?
The government has obligated $13,627 on SPE2DR26FAXAN.
Is contract SPE2DR26FAXAN an order under another contract?
Yes. SPE2DR26FAXAN is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAXAN competed?
The extent of competition for SPE2DR26FAXAN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award